Articles in Scholarly Journals [Incomplete List]

1. Advances and perspectives in Leishmania cell based drug-screening procedures
   Parasitology International, vol. 56, no. 1, pp. 3–7, 2007
2. Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice
   FEMS Immunology & Medical Microbiology, vol. 50, no. 3, pp. 333–341, 2007
3. Immunology and Molecular Biology of Protozoan Infections
   Journal of Biomedicine and Biotechnology, vol. 2007, Article ID 67210, 1 pages, 2007
4. Regulatory Cells and Immunosuppressive Cytokines: Parasite-Derived Factors Induce Immune Polarization
   Journal of Biomedicine and Biotechnology, vol. 2007, Article ID 94971, 10 pages, 2007
5. Histone Deacetylase Enzymes as Potential Drug Targets in Cancer and Parasitic Diseases
   Journal of Biomedicine and Biotechnology, vol. 2006, Article ID 13474, 10 pages, 2006
6. Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies
   Immunology, vol. 119, no. 4, pp. 529–540, 2006
7. Looking for putative functions of the Leishmania cytosolic SIR2 deacetylase
   Parasitology Research, vol. 100, no. 1, pp. 1–9, 2006
8. Proof of interaction between Leishmania SIR2RP1 deacetylase and chaperone HSP83
   Parasitology Research, vol. 100, no. 4, pp. 811–818, 2006
9. Kinetoplastid Biology and Disease, vol. 5, no. 1, p. 6, 2006
10. Kinetoplastid Biology and Disease, vol. 4, no. 1, p. 1, 2005
11. Conversion of Tc52 released factor to a protein inducing apoptosis
    Tissue and Cell, vol. 37, no. 6, pp. 469–478, 2005
12. Targeted disruption of cytosolic SIR2 deacetylase discloses its essential role in survival and proliferation
    Gene, vol. 363, pp. 85–96, 2005
13. Differential effects of polyamine derivative compounds against promastigotes and axenic amastigotes
    International Journal for Parasitology, vol. 35, no. 6, pp. 637–646, 2005
14. Antibodies against a peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment
    Immunology Letters, vol. 101, no. 1, pp. 18–23, 2005
15. Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase
    Acta Tropica, vol. 94, no. 2, pp. 107–115, 2005
16. In Vitro Antileishmanial Activity of Nicotinamide
    Antimicrobial Agents and Chemotherapy, vol. 49, no. 2, pp. 808–812, 2005
17. Differential infectivity and immunopathology in murine experimental infections by two natural clones belonging to the Trypanosoma cruzi I lineage
    Parasitology, vol. 131, no. 1, pp. 109–119, 2005
18. Host Cell Phenotypic Variability Induced by Trypanosomatid-Parasite-Released Immunomodulatory Factors: Physiopathological Implications
    Journal of Biomedicine and Biotechnology, vol. 2004, no. 3, pp. 167–174, 2004
19. Entérocolite nécrosante en fin de grossesse chez une femme opérée à l'âge de six mois d'une maladie de Hirschsprung
    Annales de Chirurgie, vol. 129, no. 1, pp. 34–36, 2004
20. Immunological alterations induced by polyamine derivatives on murine splenocytes and human mononuclear cells
    International Immunopharmacology, vol. 4, no. 4, pp. 547–556, 2004
21. Traitement cœlioscopique d'une polykystose pancréatiqueCœlioscopic treatment of pancreatic polycystic disease
    Annales de Chirurgie, vol. 128, no. 2, pp. 109–111, 2003
22. Kinetoplastid Biology and Disease, vol. 2, no. 1, p. 5, 2003
23. Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor
    Immunology, vol. 109, no. 1, pp. 147–155, 2003
24. Fatal bowel infarction due to aspergillosis after chemotherapy
    European Journal of Surgical Oncology, vol. 29, no. 7, p. 628, 2003
25. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications
    Immunology Letters, vol. 86, no. 2, pp. 155–162, 2003
26. Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele elicits attenuated Chagas' disease in mice
    Immunology Letters, vol. 89, no. 1, pp. 67–80, 2003
27. isoenzyme variability in Ecuador: first observation of zymodeme III genotypes in chronic chagasic patients
    Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 4, pp. 378–382, 2002
28. Glutathione S-transferases and related proteins from pathogenic human parasites behave as immunomodulatory factors
    Immunology Letters, vol. 81, no. 3, pp. 159–164, 2002
29. Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death
    Gene, vol. 296, no. 1-2, pp. 139–150, 2002
30. Traitement chirurgical de l'incontinence analeSurgical treatment of anal incontinence
    Annales de Chirurgie, vol. 127, no. 9, pp. 670–679, 2002
31. Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas
    Acta Tropica, vol. 80, no. 3, pp. 195–205, 2001
32. Endogenous Trypanosoma cruzi Tc52 protein expression upregulates the growth of murine macrophages and fibroblasts and cytokine gene expression
    Immunology Letters, vol. 78, no. 3, pp. 127–134, 2001
33. Antimonial-Mediated DNA Fragmentation in Leishmania infantum Amastigotes
    Antimicrobial Agents and Chemotherapy, vol. 45, no. 7, pp. 2064–2069, 2001
34. Dual Role of the Leishmania major Ribosomal Protein S3a Homologue in Regulation of T- and B-Cell Activation
    Infection and Immunity, vol. 69, no. 11, pp. 6588–6596, 2001
35. Trypanosoma Cruzi-Induced Host Immune System Dysfunction: A Rationale for Parasite Immunosuppressive Factor(s) Encoding Gene Targeting
    Journal of Biomedicine and Biotechnology, vol. 1, no. 1, pp. 11–17, 2001
36. N-Acetylcysteine and glutathione modulate the behaviour of Trypanosoma cruzi experimental infection
    Immunology Letters, vol. 71, no. 2, pp. 79–83, 2000
37. Identification and molecular characterization of two novel Trypanosoma cruzi genes encoding polypeptides sharing sequence motifs found in proteins involved in RNA editing reactions
    Gene, vol. 253, no. 2, pp. 271–280, 2000
38. Cloning of a Leishmania major gene encoding for an antigen with extensive homology to ribosomal protein S3a
    Gene, vol. 240, no. 1, pp. 57–65, 1999
39. Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele
    Molecular Microbiology, vol. 32, no. 6, pp. 1273–1286, 1999
40. A 24 000 MW Trypanosoma cruzi antigen is a B-cell activator
    Immunology, vol. 94, no. 2, pp. 189–196, 1998
41. Leishmania major: Cell type dependent distribution of a 43 kDa antigen related to silent information regulatory-2 protein family
    Biology of the Cell, vol. 90, no. 3, pp. 239–245, 1998
42. Phenotype of recombinant Trypanosoma cruzi which overexpress elongation factor 1-?: possible involvement of EF-1? GST-like domain in the resistance to clomipramine
    Gene, vol. 198, no. 1-2, pp. 259–267, 1997
43. A Leishmania major protein with extensive homology to silent information regulator 2 of Saccharomyces cerevisiae
    Gene, vol. 169, no. 1, pp. 115–118, 1996
44. Trypanosoma cruzi elongation factor 1-a: nuclear localization in parasites undergoing apoptosis
    Gene, vol. 174, no. 1, pp. 19–26, 1996
45. 2-Amino diphenylsulfides as new inhibitors of trypanothione reductase
    International Journal of Antimicrobial Agents, vol. 6, no. 2, pp. 111–118, 1995
46. High Circulating Levels of Fibronectin and Antibodies against Its RGD Adhesion Site during Mouse Trypanosoma cruzi Infection: Relation to Survival
    Experimental Parasitology, vol. 80, no. 3, pp. 499–506, 1995
47. Trypanosoma cruzi: A 52-kDa Protein Sharing Sequence Homology with Glutathione S-Transferase Is Localized in Parasite Organelles Morphologically Resembling Reservosomes
    Experimental Parasitology, vol. 81, no. 4, pp. 453–461, 1995
48. Use of a recombinant Trypanosoma cruzi protein antigen to monitor cure of Chagas disease
    Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 4, pp. 447–448, 1995
49. A novel and basic mechanism of immunosuppression in Chagas' disease: releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione
    Immunology Letters, vol. 48, no. 3, pp. 221–224, 1995
50. : Analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease
    Immunology Letters, vol. 48, no. 3, pp. 193–200, 1995
51. Molecular cloning of aTrypanosoma cruzi cDNA encoding a protein homologous with mammalian elongation factor 1?
    Parasitology Research, vol. 80, no. 7, pp. 626–628, 1994
52. Trypanosoma cruzi cDNA encodes a tandemly repeated domain structure characteristic of small stress proteins and glutathione S-transferases
    Biology of the Cell, vol. 80, no. 1, pp. 1–10, 1994
53. Molecular and immunological characterization of a Trypanosoma cruzi protein homologous to mammalian elongation factor 1 gamma
    Biology of the Cell, vol. 82, no. 1, pp. 39–44, 1994
54. glutathione-binding proteins (TcGBP) : protection induced by native proteins in an experimental model and analysis of the antibody response
    Research in Immunology, vol. 144, no. 8, pp. 553–563, 1993
55. attachment of from mouse and rat origin
    Biology of the Cell, vol. 77, pp. 209–217, 1993
56. Cloning and sequencing of a 24-kDa Trypanosoma cruzi specific antigen released in association with membrane vesicles and defined by a monoclonal antibody
    Biology of the Cell, vol. 75, no. 1, pp. 11–17, 1992
57. Trypanosoma cruzi: Infection of T lymphocytes and their destruction by antibody-dependent cell-mediated cytotoxicity
    European Journal of Immunology, vol. 21, no. 9, pp. 2145–2152, 1991
58. Trypanosoma cruzi: Differential expression and distribution of an 85-kDa polypeptide epitope by in vitro developmental stages
    Experimental Parasitology, vol. 71, no. 2, pp. 207–217, 1990
59. Some aspects of protozoan parasite-host cell interactions with special reference to RGD-mediated recognition process
    Microbial Pathogenesis, vol. 6, no. 1, pp. 1–5, 1989
60. Role of the RGD sequence in parasite adhesion to host cells
    Parasitology Today, vol. 4, no. 6, pp. 169–173, 1988
61. The major surface protein ofleishmania promastigotes is a fibronectin-like molecule
    European Journal of Immunology, vol. 18, no. 3, pp. 473–476, 1988
62. Identification of anti-acetylcholinesterase and anti-idiotype antibodies in human and experimental Chagas+ disease: pathological implications
    European Journal of Immunology, vol. 18, no. 12, pp. 1889–1894, 1988
63. Fluorescence-Activated Cell-Sorting Analysis of Fibronectin Peptides Binding to Trypanosoma cruzi Trypomastigotes
    The Journal of Eukaryotic Microbiology, vol. 35, no. 1, pp. 111–114, 1988
64. Trypanosoma cruzi: Ultrastructural visualization of fibronectin bound to culture forms
    Experimental Parasitology, vol. 63, no. 1, pp. 112–114, 1987
65. Trypanosoma cruzi: Cell type dependent distribution of a tubulin domain in mammalian stages
    Experimental Parasitology, vol. 64, no. 2, pp. 133–138, 1987
66. Identification and isolation of Trypanosoma cruzi trypomastigote cell surface protein with properties expected of a fibronectin receptor
    Molecular and Biochemical Parasitology, vol. 19, no. 3, pp. 201–211, 1986
67. Trypanosoma cruzi: modulation of parasite-cell interaction by plasma fibronectin
    European Journal of Immunology, vol. 15, no. 11, pp. 1096–1101, 1985
68. Fibronectin receptors on Trypanosoma cruzi trypomastigotes and their biological function
    Nature, vol. 308, no. 5957, Article ID 308380a0, 2 pages, 1984
69. Schistosoma mansoni: Ultrastructural damages due to complement on schistosomula in vitro
    Experimental Parasitology, vol. 50, no. 1, pp. 74–82, 1980
70. Interaction between Schistosoma mansoni and the complement system. Receptors for C3b on cercariae and schistosomula
    Immunology Letters, vol. 1, no. 4, pp. 197–201, 1980
71. Freeze-fracture study of immune-induced Schistosoma mansoni membrane alterationsI. Complement-dependent damage in the presence of antisera to host antigenic Determinants
    Journal of Ultrastructure Research, vol. 67, no. 3, pp. 276–287, 1979
72. Receptor for IgG(Fc) and human ß2-microglobulin on S. mansoni schistosomula
    Nature, vol. 278, no. 5703, Article ID 278447a0, 2 pages, 1979